Finland· FI-REL-REL1667

Glycostigmin

A neostigmin, kombinationen product containing neostigmine metilsulfate + glycopyrronium bromide, registered in Finland by Evolan Pharma AB. The same ATC class is registered in 6 of our 19 countries.

ATC N07AA51

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedGlycostigminATCN07AA51REGISTER NO.FI-REL-REL1667PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Neostigmin, kombinationen is registered in 6 of 19 countries.

Countries holding a registration under ATC N07AA51 (neostigmin, kombinationen), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Neostigmin, kombinationen · ATC N07AA51

6 / 19 countries

  • Denmark
  • Finlandprice
  • Ireland
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Neostigmine metilsulfate + Glycopyrronium bromide
Manufacturer
Evolan Pharma AB
Country
Finland (FI)
ATC code
N07AA51
ATC class
Neostigmin, Kombinationen
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Neostigmin, kombinationen in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All neostigmin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Combistig
  • Belgium · Robinul-Neostigmine
  • Denmark · Copneg, Robinul-Neostigmin
  • Estonia · Glynex
  • United Kingdom (Northern Ireland) · Glycopyrrolate And Neostigmine Metilsulfate Mercury Pharmaceuticals Ltd,, Glycopyrronium Bromide And Neostigmine Metilsulfate Martindale Pharmaceuticals
  • Croatia · Novistig
  • Hungary · Novistig
  • Ireland · Glycopyrronium Bromide And Neostigmine Metilsulfate Mercurypharm, Novistig
  • Luxembourg · Robinul-Neostigmine
  • Norway · Copneg, Robinul-Neostigmin
  • Poland · Novistig
  • Sweden · Copneg, Robinul
  • Slovenia · Novistig

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5943eed4-4fc9-4f15-ab8e-3d89b667b89e
GET /v1/drugs/5943eed4-4fc9-4f15-ab8e-3d89b667b89e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1",
  "form": "injektioneste, liuos",
  "route": "Laskimoon",
  "ddd_unit": "ED",
  "strength": null,
  "atc_label": "neostigmiini, yhdistelmävalmisteet",
  "ma_number": "10970",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL1667",
  "authorised_at": "1993-05-24"
}

See everything about neostigmin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.